| Trial Identifier: | D589BC00027 |
| Sponsor: | AstraZeneca |
| Start Date: | July 2022 |
| Primary Completion Date: | September 2024 |
| Study Completion Date: | September 2024 |
| Condition: | Asthma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Chinese (China) Translation |
| Country | Location |
|---|---|
| CN | Beijing, CN, 100020 |
| CN | Beijing, CN, 100080 |
| CN | Beijing, CN, 100050 |
| CN | Changchun, CN, 130033 |
| CN | changsha, CN, 410005 |
| CN | Changzhi, CN, 046000 |
| CN | Chengdu, CN, 610021 |
| CN | Chongqing, CN, 404197 |
| CN | Dalian, CN, 116011 |
| CN | Foshan, CN, 528315 |
| CN | Guangzhou, CN, 510620 |
| CN | Handan, CN, 056000 |
| CN | Harbin, CN, 150001 |
| CN | Hebi, CN, 458000 |
| CN | Hefei, CN, 230011 |
| CN | Huai'an, CN, 223000 |
| CN | Jinan, CN, 250031 |
| CN | Jinhua, CN, 322100 |
| CN | Kunming, CN, 650051 |
| CN | Kunshan, CN, 215316 |
| CN | Nanchang, CN, 331700 |
| CN | nanning, CN |
| CN | Ningbo, CN, 315040 |
| CN | Shanghai, CN, 200030 |
| CN | Shanghai, CN, 200080 |
| CN | shiyan, CN, 442005 |
| CN | Taizhou, CN, 317100 |
| CN | Tianjin, CN, 300450 |
| CN | Wuhu, CN, 241000 |
| CN | Wuyishan, CN, 354300 |
| CN | Xi'an, CN, 710038 |
| CN | Yantai, CN, 265701 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company